Using drug response data to identify molecular effectors, and molecular “omic” data to identify candidate drugs in cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Using drug response data to identify molecular effectors, and molecular “omic” data to identify candidate drugs in cancer

Published:2014-09-12 Issue:1 Volume:134 Page:3-11
ISSN:0340-6717
Container-title:Human Genetics
language:en
Short-container-title:Hum Genet

Author:

Reinhold William C.,Varma Sudhir,Rajapakse Vinodh N.,Luna Augustin,Sousa Fabricio Garmus,Kohn Kurt W.,Pommier Yves G.

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://link.springer.com/content/pdf/10.1007/s00439-014-1482-9.pdf

Reference71 articles.

1. Abaan OD, Polley EC, Davis SR, Zhu YJ, Bilke S, Walker RL, Pineda M, Gindin Y, Jiang Y, Reinhold WC, Holbeck SL, Simon RM, Doroshow JH, Pommier Y, Meltzer PS (2013) The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. Cancer Res 73:4372–4382. doi: 10.1158/0008-5472.CAN-12-3342

2. Adams S, Robbins FM, Chen D, Wagage D, Holbeck SL, Morse HC 3rd, Stroncek D, Marincola FM (2005) HLA class I and II genotype of the NCI-60 cell lines. J Transl Med 3:11. doi: 10.1186/1479-5876-3-11

3. Aksoy BA, Demir E, Babur O, Wang W, Jing X, Schultz N, Sander C (2014) Prediction of individualized therapeutic vulnerabilities in cancer from genomic profiles. Bioinformatics. doi: 10.1093/bioinformatics/btu164

4. Algeciras-Schimnich A, Pietras EM, Barnhart BC, Legembre P, Vijayan S, Holbeck SL, Peter ME (2003) Two CD95 tumor classes with different sensitivities to antitumor drugs. Proc Natl Acad Sci USA 100:11445–11450. doi: 10.1073/pnas.2034995100

5. Amundson SA, Do KT, Vinikoor LC, Lee RA, Koch-Paiz CA, Ahn J, Reimers M, Chen Y, Scudiero DA, Weinstein JN, Trent JM, Bittner ML, Meltzer PS, Fornace AJ Jr (2008) Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Res 68:415–424. doi: 10.1158/0008-5472.CAN-07-2120

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy;Drug Resistance Updates;2024-03

2. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma;Journal of Trace Elements in Medicine and Biology;2022-12

3. Identification of phenocopies improves prediction of targeted therapy response over DNA mutations alone;npj Genomic Medicine;2022-10-17

4. The IC-50-time evolution is a new model to improve drug responses consistency of large scale studies;F1000Research;2022-03-07

5. Identification of biological targets through the correlation between cell line chemosensitivity and protein expression pattern;Drug Discovery Today;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3